Eli Lilly Organizational Structure & Org Chart

Eli Lilly's public structure is best understood through Diabetes and Obesity, Oncology, Neuroscience, Immunology. The interactive chart is a researched, editable map of those published areas.

Eli Lilly organizational chart

Edit this organizational chart

Eli Lilly's reporting structure as of 2026-09. Drag to pan, scroll to zoom — or open it in QueryChart and edit it as your own.

Industry: Biopharmaceuticals
Headquarters: Indianapolis, Indiana, United States
Founded: 1876
CEO: David Ricks
Ownership: Public
Structure as of: 2026-09
Structure last reviewed: 2026-09-29

About the company

Eli Lilly is a biopharmaceuticals organization. Its current public materials identify Diabetes and Obesity, Oncology, Neuroscience, Immunology as useful ways to understand its activities. Lilly reports one financial segment for pharmaceuticals, yet its executive leadership names therapeutic businesses including diabetes and obesity, oncology, neuroscience and immunology. The branches are a portfolio view, not four reportable segments.

This QueryChart tree puts those disclosed areas next to a single, separately marked leadership branch for David Ricks. The business branches describe a public portfolio, not a confidential employee hierarchy. A line between a category and an offering means the offering belongs in that published category; it does not say that a particular executive personally manages every team shown.

Published businesses and operating areas

Diabetes and Obesity is one of the visible areas in Eli Lilly's published structure. The therapeutic portfolio includes metabolic medicines and associated research. The editable chart places Diabetes medicines and Obesity medicines beneath this branch so a reader can find concrete activities instead of a generic departmental box. This is a simplified grouping of disclosed work, and the sources below should be used for the exact legal entities, segment definitions and current management roles.

Oncology is one of the visible areas in Eli Lilly's published structure. Cancer medicines and development work are led as a named therapeutic business. The editable chart places Cancer portfolio and Oncology development beneath this branch so a reader can find concrete activities instead of a generic departmental box. This is a simplified grouping of disclosed work, and the sources below should be used for the exact legal entities, segment definitions and current management roles.

Neuroscience is one of the visible areas in Eli Lilly's published structure. Neuroscience work addresses disorders of the brain and nervous system. The editable chart places Neuroscience medicines and Research programs beneath this branch so a reader can find concrete activities instead of a generic departmental box. This is a simplified grouping of disclosed work, and the sources below should be used for the exact legal entities, segment definitions and current management roles.

Immunology is one of the visible areas in Eli Lilly's published structure. The immunology portfolio develops and commercializes medicines for immune-mediated disease. The editable chart places Immunology medicines and Clinical development beneath this branch so a reader can find concrete activities instead of a generic departmental box. This is a simplified grouping of disclosed work, and the sources below should be used for the exact legal entities, segment definitions and current management roles.

Key leadership roles

David Ricks
Chairman, President and Chief Executive Officer

How this structure supports the business

The Diabetes and Obesity and Oncology branches answer different questions about Eli Lilly. The therapeutic portfolio includes metabolic medicines and associated research. Cancer medicines and development work are led as a named therapeutic business. Showing them side by side is more informative than drawing an unsupported chain of managers, particularly when the public materials report a portfolio or service line rather than a complete internal org chart.

Lilly reports one financial segment for pharmaceuticals, yet its executive leadership names therapeutic businesses including diabetes and obesity, oncology, neuroscience and immunology. The branches are a portfolio view, not four reportable segments. Neuroscience work addresses disorders of the brain and nervous system. The diagram makes that distinguishing feature visible while keeping the named leadership layer separate. It is useful as a starting point for an editable company chart; users can replace the public groupings with their own teams, roles and verified reporting relationships.

Advantages and disadvantages

The Diabetes and Obesity branch uses a publicly described company-specific grouping.: A portfolio branch does not prove an individual reporting line.
The chart distinguishes Oncology from Neuroscience.: A single-parent tree cannot show every cross-business collaboration or legal-entity link.

Interesting facts

Eli Lilly's public materials identify Diabetes and Obesity as a major area.
Oncology includes Cancer portfolio and Oncology development in this educational map.
Neuroscience is shown separately because neuroscience work addresses disorders of the brain and nervous system.
The principal leadership role is identified as David Ricks (Chairman, President and Chief Executive Officer).

Related process templates

Related organization charts

Frequently asked questions

How is Eli Lilly organized?

This educational chart maps Diabetes and Obesity, Oncology, Neuroscience, Immunology, using the company's public materials. It does not attempt to reproduce a full internal employee hierarchy.

Who leads Eli Lilly?

David Ricks is the publicly identified Chairman, President and Chief Executive Officer in the sources reviewed on 29 September 2026.

Is this an official Eli Lilly org chart?

No. It is an independent reconstruction of public business categories and leadership information, with simplified connections for exploration and editing.

Use this org chart template

Open this Eli Lilly structure in QueryChart and rename roles, add departments, remove areas or change connections for your own organization.